We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0QXH Epigenomics Ag

0.00 (0.00%)
27 Feb 2024 - Closed
Delayed by 15 minutes

Epigenomics Financial Summary

The current 0QXH market cap is 7.66M. The company's latest EPS is EUR -2.8183 and P/E is -0.62.

Year End 31 December 2022 20182019202020212022
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 1.53M1.13M843k6.2M485k
Operating Income -13.29M-15.1M-10.11M-4.16M-12.86M
Net Income -12.69M-17.02M-11.69M-2.43M-12.02M
Year End 31 December 2022 20182019202020212022
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 21.83M13.99M6.8M24.66M15.85M
Total Liabilities 3.21M4.36M2.93M2.54M5.68M
Total Equity 18.61M9.63M3.86M22.12M10.17M

Cash Flow

Year End 31 December 2022 20182019202020212022
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Operating -10.35M-13.51M-9.57M-4.15M-12.02M
Investing 724k47k3k961k-1.7M
Financing 13.27M7.12M2.98M21.62M-359k
Market Cap 7.66M
Price to Earnings Ratio -0.62
Price to Sales Ratio 15.3
Price to Cash Ratio 0.73
Price to Book Ratio 0.73
Dividend Yield -

Share Statistics

Shares Outstanding 4.27M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change 0.00%
52 Week High 1.796
52 Week Low 1.796
Spread (Intraday) 0.15 (7.91%)

Company Info

Company Name Epigenomics Ag
Address geneststra��e 5
berlin 10829
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |